Coronavirus channel feed

Covid-19 roundup: Mod­er­na sub­mits vac­cine for full ap­proval; WHO un­veils new Greek-based sys­tem for nam­ing vari­ants

4 years ago

Covid-19 roundup: UK au­tho­rizes J&J vac­cine; UNICEF buys 220 mil­lion dos­es of Russ­ian vac­cine

4 years ago

The man­u­fac­tur­ing hold at Emer­gen­t's Bal­ti­more Bayview plant could be com­ing to an end — re­port

4 years ago
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: WHO let­ter out­lines re­boot of IP shar­ing pro­gram; In­dia backs down on do­mes­ti­cal­ly-pro­duced vac­cine tri­al

4 years ago
Manufacturing

Eli Lil­ly's much-ma­ligned Branch­burg plant earns a fed­er­al sub­poe­na amid whistle­blow­er claims tied to Covid-19 work

4 years ago
Manufacturing

US paus­es use of Eli Lil­ly Covid-19 mAb com­bo in six more states due to vari­ants from Brazil, In­dia

4 years ago
Pharma

Covid-19 roundup: Pres­i­dent Biden or­ders in­tel­li­gence com­mu­ni­ty to re­dou­ble ef­forts to de­ter­mine if virus orig­i­nat­ed in an­i­mals or a lab in Chi­na

4 years ago

FDA au­tho­rizes Vir-GSK an­ti­body as vari­ants threat­en Eli Lil­ly mAb

4 years ago
R&D

Mer­ck KGaA draws the cur­tain on newest lipid nanopar­ti­cle for mR­NA vac­cines, tur­bocharg­ing its an­nu­al ca­pac­i­ty

4 years ago
Manufacturing

Covid-19 roundup: French in­flu­encers tar­get­ed in mis­in­for­ma­tion cam­paign against Pfiz­er; As­traZeneca and the EU le­gal case be­gins

4 years ago

FDA clos­es the door on EUA re­quests for some fu­ture Covid-19 vac­cines

4 years ago
FDA+

Spurred on by Mod­er­na and Pfiz­er's suc­cess, a Bel­gian biotech has big am­bi­tions for its self-am­pli­fy­ing RNA vac­cine play

4 years ago
Financing

Covid-19 roundup: Mod­er­na says vac­cine safe, ef­fec­tive in ado­les­cents; CEPI backs a syn­thet­ic bi­ol­o­gy vac­cine for PhI­II

4 years ago

Covid-19 roundup: Mod­er­na inks fill-fin­ish pact with Sam­sung Bi­o­log­ics; So­ri­ot dis­cuss­es vac­cine woes, says shot 'has a fu­ture' — re­port

4 years ago

US paus­es dis­tri­b­u­tion of Lil­ly mAb com­bo to Mass­a­chu­setts due to Covid-19 vari­ant

4 years ago
FDA+

Covid-19 roundup: Mod­er­na's jab gains ap­proval in Japan and South Ko­rea; J&J and Gavi reach agree­ment for 200M more dos­es

4 years ago

Re­silience has caught the eye of the Cana­di­an gov­ern­ment, which will in­vest $163M to boost mR­NA pro­duc­tion

4 years ago
Manufacturing

Af­ter record-break­ing de­mand for in­jecta­bles, BD to ex­pand in Spain with $200M Zaragoza plant

4 years ago
Manufacturing

Covid-19 man­u­fac­tur­ing re­port: Ire­land will pro­duce mR­NA com­po­nent for Pfiz­er's vac­cine; Lon­za re­cruits fed­er­al em­ploy­ees for rapid ramp-up

4 years ago
Manufacturing

HIV re­searcher David Ho has a new line of at­tack on SARS-CoV-2, and his fledg­ling start­up is gun­ning for the clin­ic

4 years ago
Financing
Startups

Mi­nor­i­ty pa­tients un­der­rep­re­sent­ed in Covid-19 tri­als de­spite greater will­ing­ness to par­tic­i­pate, re­port finds

4 years ago

Covid-19 roundup: Eu­rope re­serves 1.8 bil­lion dos­es of Pfiz­er vac­cines; Re­pub­li­cans slam Biden's TRIPS waiv­er sup­port

4 years ago

Covid-19 roundup: Study sug­gests As­traZeneca/Ox­ford boost­er is ef­fec­tive against vari­ants — re­port; IF­P­MA is­sues guid­ance on vac­cine in­equity

4 years ago

Covid-19 roundup: US to do­nate 20M more vac­cines over­seas; BerGen­Bio hopes for the best af­ter re­pur­pos­ing flop, tout­ing post hoc da­ta

4 years ago
First page Previous page 26272829303132 Next page Last page
A service from the Financial Times